Objective To investigate the relationship between viral load and secondary transmission in
novel coronavirus disease 2019 (COVID-19). Methods Epidemiological and clinical data …

This study aimed to determine the frequency of SARS‐CoV‐2 RNA in serum and its
association with the clinical severity of COVID‐19. This retrospective cohort study performed at …

Vancomycin (VCM) and daptomycin (DAP) are standard therapies for methicillin-resistant
Staphylococcus aureus (MRSA) bacteremia, despite concerns regarding clinical utility and …

Serological tests are beneficial for recognizing the immune response against severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2). To identify protective immunity, …

Background The role of type I interferons (IFNs) in the early phase of COVID-19 remains
unclear. Objectives To evaluate the relationship between IFN-I levels in patients with COVID-19 …

In addition to the original monovalent vaccines available for SARS-CoV-2, bivalent vaccines
covering wild-type (WT) and Omicron BA.1 are also available. However, there is a lack of …

Vaccines against severe acute respiratory syndrome coronavirus-2 have been introduced.
To investigate the relationship between vaccine-induced humoral immunity and patient age, …

Adaptive immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
dynamics remain largely unknown. The neutralizing antibody (NAb) levels in patients with …

Background Time-dependent changes in cell populations during acute bacterial infections
remain unclear. We assessed time-dependent changes in fluorescent light intensity of the …

Introduction The vaccine against SARS-CoV-2 provides humoral immunity to fight COVID-19;
however, the acquired immunity gradually declines. Booster vaccination restores reduced …